Carregant...
Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin
BACKGROUND: Intact proinsulin is a biomarker for pancreatic ß-cell dysfunction. In large prospective studies in nondiabetic subjects, elevated intact proinsulin predicted development of type 2 diabetes and/or macrovascular events up to 7 years in advance. This study was performed to evaluate a new s...
Guardat en:
| Publicat a: | J Diabetes Sci Technol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5478019/ https://ncbi.nlm.nih.gov/pubmed/27559030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296816663745 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|